U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Dec. 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for ...
Dublin, Ireland -- November 19, 2015 – Adapt Pharma Limited (www.adaptpharma.com) announced today that the U.S. Food and Drug Administration (FDA) has approved NARCAN® (naloxone hydrochloride) Nasal ...
Market players are involved in product launches and approvals, which is expected to drive growth of the global naloxone market. For instance, in December 2021, Sandoz AG, a Novartis division, launched ...
DUBLIN, April 9, 2018 /CNW/ -- Adapt Pharma today welcomed the important steps recently taken by both the Ontario Government, and the Canadian Government to help address the opioid crisis, through ...
Governor Gavin Newsom announced on Friday that CalRx will drive down the cost of naloxone as the state program reverses ...
What you need to know: As the state tracks nearly 400,000 overdoses reversed through the Naloxone Distribution Project, the ...
Naloxone hydrochloride nasal spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression for adult and ...
Kloxxado is intended for immediate administration as emergency therapy in settings where opioids may be present. The Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. On Tuesday, the Food and Drug Administration (FDA) announced that it ...
In the latest maneuver in the battle against opioid deaths in California, Gov. Gavin Newsom announced Monday that all Californians can now buy naloxone anti-overdose nasal spray directly the state for ...
The Food and Drug Administration (FDA) on Friday announced that it granted final approval to the first generic naloxone hydrochloride nasal spray, which can be used to reverse opioid overdoses. The ...